Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_assertion type Assertion NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_head.
- NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_assertion description "[The UHRF1 DNA in plasma of 229 breast cancer patients showed higher expression than healthy controls, which showed high specificity up to 76.2% at a sensitivity of 79.2%, and was significantly associated with c-erbB2 positive status, cancer stage and lymph node metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_provenance.
- NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_assertion evidence source_evidence_literature NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_provenance.
- NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_assertion SIO_000772 23107467 NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_provenance.
- NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_assertion wasDerivedFrom befree-20140225 NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_provenance.
- NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_assertion wasGeneratedBy ECO_0000203 NP478839.RA6EQ2XFm6obfpM5GR18hywiBI4RVL3LEDsANLPfuHp_s130_provenance.